Cardiology Outline Cardiology Consist: Clinical Cardiology, Invasive & Non-invasive Cardiology, Cardiac Electrophysiology, and Interventional Cardiology

General Training days

Tuesday 23 October 2012 General Day 1: Chest Pain & Stable Angina Tuesday 11 December 2012 General Day 2: Acute coronary syndromes and myocardial infarction Tuesday 22 January 2013 General Day 3: Cardiovascular response to exercise in health and disease; Cardiac rehabilitation Monday 11 February 2013 General Day 4: Heart failure Day 2 Friday 1 March 2013 General Day 5: Assessment and care of patients before and after cardiac and non-cardiac, surgery Wednesday 17 April 2013 General Day 6: Heart Disease in Pregnancy Thursday 20 June 2013 General Day 7: The prevention and management of endocarditis Friday 5 July 2013 General Day 8: Pre-syncope, syncope and Bradyarrhythmias

Electrophysiology sub specialty training

Monday 3 December 2012 Day 1: Narrow complex tachycardia II Monday 14th January 2013 Day 2: Cardiac arrhythmias and sudden death: From Bench to Bedside Thursday 14 February 2013 Day 3: "Pacemaker implantation & programming, managing device-related complications Lead management, engineering" Friday 12 April 2013 Day 4: Narrow complex tachycardia III Tracings Tuesday 14 May 2013 Day 5: Heart Failure and EP Tuesday 4 June 2013 Day 6: Title to be confirmed

Wednesday 3 July 2013 Day 7: Atrial tachycardia

Cardiac imaging sub specialty training

Friday 12 October 2012 Cardiac Imaging Day 1 Wednesday 7 November 2012 Cardiac Imaging Day 2 Friday 8 February 2013 Cardiac Imaging Day 3 Friday 22 February 2013 Cardiac Imaging Day 4 Monday 25 March 2013 Cardiac Imaging Day 5/ BSE Monday 29 April 29 2013 Cardiac Imaging Day 6 Thursday 27June 27 2013 Cardiac Imaging Day 7

Intervention sub specialty training

Friday 2 November 2012 Coronary artery assessment: Pressure and flow wire, IVUS, OCT Wednesday 16 January 2013 Non-coronary intervention: Valves, septal ablation, PFO/ASD, carotid and renal interventions Tuesday 12 February 2013 Trial evaluation: design, statistics, interpretation Wednesday 6 March 2013 PCI for STEMI/ACS: 2b3a, bival, PCI in NSEACS including timing Friday 19 April 2013 Complications of PCI: Peri-and post-procedure, recognition and management Thursday 6 June 2013 Complex PCI: CTOs, SVG, LM, bifurcations, calcified lesions

Heart failure sub specialty training

Friday 7 December 2012

Heart Failure Day 1 Friday 7 June 2013 Heart Failure Day 1 (also see General day 4 for Heart Failure Day 2)

Adult congenital heart disease

Monday 11 March 2013 ACHD Day1 Friday 27 September 2013 ACHD Day 2

Hypertension
Section 3: Genetics of Hypertension I. Monogenic causes of human hypertension A. Glucocorticoid remediable aldosteronism B. Liddles syndrome C. Apparent mineralocorticoid excess D. Congenital adrenal hyperplasias 1. Caused by mutations in 11--hydroxylase 2. Caused by mutations in 17--hydroxylase E. Pseudohypoaldosteronism Type II F. Hypertension + brachydactyly syndrome G. Gain of function mutation ofthe mineralocorticoid receptor II. Genetics of human primary hypertension A. Risk of primary hypertension in population B. Risk of primary hypertens ion in individuals with positive family history C. Polygenic nature D. Familial clustering of other cardiovascular risk factors E. Renal involvement F. Pharmacogenetic implications Section 4: Pathophysiologic Mechanisms of Hypertension I. Hemodynamic Subsets II. Neural Mechanisms III. Renal Mechanisms IV. Vascular Mechanisms V. Hormonal Mechanisms A. Renin-Angiotensin-Aldosterone System

B. Endothelin C. Insulin Resistance/Obesity Section 5: Diagnostic Assessment I. Accurate and adequate measurement of blood pressure (BP) A. Office B. Automatic ambulatory monitoring C. Home, self- recorded II. Additional assessment of prognosis A. Nocturnal pattern of BP B. BP on arising C. BP during exercise D. Masked hypertension III. White coat hypertension IV. Initial evaluation A. Purposes 1. Recognize specific identifiable causes of hypertension 2. Assess target organ damage 3. Determine overall cardiovascular risk status B. Procedures 1. History 2. Physical examination, including fundoscopic 3. Laboratory testing: routine and additional as indicated V. Overall cardiovascular risk stratification Section 6: Metabolic Abnormalities and Hypertension I. Obesity related hypertension A. Prevalence of the association

B. Pathophysiology C. Evaluation D. Management II. Dyslipidemia A. Prevalence of the association B. Mechanisms C. Management III. The metabolic syndrome A. Components of the syndrome B. Pathophysiology C. Management IV. Diabetes mellitus A. Prevalence of the association with types 1 and 2 diabetes B. Pathophysiology C. Evaluation D. Management